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Heart rate variability (HRV) is a non-invasive quantitative marker of cardiac autonomic function 
derived from continuous electrocardiogram (ECG) recordings. Normative HRV values and 
development factors have not been established in pediatric populations. The objective was to 
derive referent time- and frequency-domain HRV values for a population-based sample of 
children. Children aged 9–11 years (N = 1,036) participated in the Québec Longitudinal Study of 
Child Development cohort cardiovascular health screening. Registered nurses measured 
anthropometrics (height, weight) and children wore an ambulatory Holter monitor to continuously 
record an ECG signal. HRV variables included time (SDNN, pNN50, RMSSD, SDANN) and 
frequency (HF, LF, LF/HF ratio) domain variables. Normative HRV values, stratified by age, sex, 
and heart rate, are presented. Greater heart rate (βavg = −0.60, ), pubertal maturation 
(βavg = −0.11, ), later ECG recording times (βavg = −0.19, ), and higher 
diastolic blood pressure (βavg = −0.11, ) were significantly associated with reduced 
HRV in 10-year-old children. The normative HRV values permit clinicians to monitor, describe, 
and establish pediatric nosologies in primary care and research settings, which may improve 
treatment of diseases associated with HRV in children. By better understanding existing values, 
the practical applicability of HRV among clinicians will be enhanced. Lastly, developmental (e.g., 
puberty) and procedural (e.g., recording time) factors were identified that will improve recording 
procedures and interpretation of results.
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Introduction
Heart rate variability (HRV) is a non-invasive measure of cardiac autonomic function 
derived from continuous electrocardiogram (ECG) recordings [1]. In primary health care 
settings, ECG recordings and HRV are used by physicians as part of an initial screening tool, 
for early diagnosis of potentially detrimental illnesses (e.g., for suspected cardiac 
abnormalities), and to monitor physiological processes using HRV as a physiomarker [15]. 
The clinical relevance of HRV was first acknowledged when alterations in inter-beat 
intervals were observed prior to fetal distress [13]. Since then, reduced HRV, reflective of the 
inability or attenuation of the autonomic regulatory capacity to support flexible adjustments 
in response to the environment [40], has been implicated in a number of pediatric cardiac 
(e.g., arrhythmias, heart disease) [39] and non-cardiac pathologies (e.g., obesity; 6–7). 
Growing evidence suggests that cortico-subcortical networks which regulate autonomic 
balance, as indicated by low HRV, may structurally and functionally link psychological 
processes (e.g., negative affective states) with adverse health conditions, including immune 
dysfunction, emotional dysregulation, as well as poor use of cognitive resources [40].
Despite the increased use of HRV in the research literature, normative pediatric values are 
limited and few studies report referent values [18, 43]. Existing referent values are based on 
studies with methodological limitations including use of small samples (e.g., 10), combining 
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broad age ranges [18], use of convenience “healthy controls” [5, 35] or clinical samples [3], 
varying duration of ECG recording (e.g., 2 min to 24 h), inaccurate frequency bandwidths 
for spectral analysis parameters [7, 10, 26], and reporting HRV values using inconsistent 
units (e.g., beats/min2, log transformed, absolute, normalized). Further, important 
developmental factors are often not considered. Limited findings suggest younger age [19, 
37], pubertal status [5], greater physical activity [5, 26], and consolidated sleep [18, 19] are 
associated with a predominance of parasympathetic activity and reduced sympathetic 
modulation; yet, these have not been considered when deriving normative values. 
Collectively, these limitations hinder and bias interpretation and their practical applicability 
among clinicians.
In sharp contrast, numerous adult population-based studies report referent HRV values, 
stratified by sex, age, and heart rate, and account for factors including adiposity, blood 
pressure, medication use, and physical activity [2, 21, 38, 39, 42]. Unique developmental 
changes and pediatric milestones preclude these adult findings from being extrapolated to 
children. Altogether, the state of knowledge regarding “normal” HRV values in children is 
rather haphazard [8, 23, 37, 43]. The objectives of the present study were twofold. The first 
objective was to provide time- and frequency-domain HRV values for a population-based 
sample of 10-year-old children. The second objective was to comprehensively assess 
associations with developmental factors on HRV.
Method
Participants
Children (N = 1,052) participated in the population-based Québec Longitudinal Study of 
Child Development (QLSCD), an ongoing longitudinal study conducted by the Institut de la 
statistique du Québec [14]. Using a multistage cluster (by region and municipality) random 
sampling strategy, the original birth cohort was selected from the Quebec Ministry of Health 
birth registry, which was representative of singleton births from 1996 to 1998. Exclusion 
criteria included serious medical pathology, infants born <24 or >42 weeks gestation (0.1 %) 
or those with unknown gestational age (1.3 %), families living in Aboriginal territories or 
remote regions of Québec, and parents who did not understand French or English. The 
original QLSCD sample represented 97.8 % of the target population and was approved by 
the ethics review boards of the Institut de la statistique du Québec, the Centre Hospitalier 
Universitaire Sainte-Justine, the Louis-Hippolyte Lafontaine Hospital, and the Université de 
Montréal Faculty of Medicine. Present data are derived from the cross-sectional, 
cardiovascular health screening at age 10, conducted between 2006 and 2008, as part of the 
QLSCD annual follow-up. (Further information on methodology http://
www.jesuisjeserai.stat.gouv.qc.ca/default_an.htm).
Measures
ECG Signal Acquisition—Following a 20 min resting period, continuous raw ECG data 
were acquired, digitized, and recorded (8500 Marquette MARS Holter monitor; GE 
Marquette Medical Systems, Milwaukee, Wisconsin, USA) during a standardized procedure. 
Following skin preparation, pre-gelled silver chloride electrodes were attached in a Lead II 
Jarrin et al. Page 3



















configuration. The recording protocol was standardized and lasted an hour in duration (SD = 
21 min). All monitors were calibrated, and start and end times were noted and recorded by 
the nurse (i.e., event marker); the majority of recordings took place between 8 and 11 am.
ECG Signal Processing—ECG data were uploaded on the MARS® Holter Analysis 
Workstation (GE Marquette Medical Systems, Milwaukee, Wisconsin, USA) for signal 
interpretation and analysis. Beat-by-beat visual inspection of the shape, trend, and length of 
each QRS complex was identified based on standard Marquette algorithms for QRS labeling 
and further verified by visual inspection from a qualified trained professional. ECG data 
were sampled at 1,024 samples/300 s, and RR intervals were automatically filtered. The 
removal of artifacts was based on a 20 % change from the previous signal as a criterion [17].
Data were processed by Fast Fourier Transform (FFT) spectral analysis method. Frequency-
domain variables included very low frequency (VLF, 0.0033–0.04 Hz), low frequency (LF, 
0.04–0.15 Hz), high frequency (HF, 0.15–0.4 Hz), and LF:HF ratio; these were quantified 
and expressed in absolute units. Time-domain variables included standard deviation of all 
normal sinus RR intervals (SDNN), standard deviation of the averaged normal sinus RR 
intervals for all 5-min epochs (SDANN), SDNNi (mean of the standard deviations of all 
normal sinus RR intervals for all 5-min epochs), root mean square of the successive normal 
sinus RR interval difference (rMSSD), and percentage of successive normal sinus RR 
intervals <50 ms (pNN50).
Blood Pressure
A pediatric- or appropriately-sized occlusion cuff was attached to the medial surface of the 
right arm over the brachial artery using an oscillometric instrument (BpTRU, model 
BPM-100, VSM MedTech Ltd, Vancouver, Canada) according to standardized procedures 
[47]. Units were routinely calibrated with a mercury sphygmomanometer to ensure 
precision. Following a seated resting baseline, five readings were taken at 1 min intervals; 
the mean of the last four readings was calculated for systolic and diastolic blood pressure 
(SBP, DBP).
Anthropometrics
A registered nurse assessed anthropometrics. Waist circumference was measured at the 
narrowest part of the abdomen, midway between the lowest rib and the iliac crest. Height 
(shoes off) and weight (dressed in light clothing) were measured in duplicate; triplicate 
measures were taken if measures differed by 0.5 cm or 0.2 kg, respectively. The mean of the 
two closest measurements was used. Body mass index (BMI) [weight kg/(height m2)] was 
calculated and converted to age-and sex-specific BMI Z scores [28].
Puberty
Using a validated self-report measure of puberty (Growing and Changing Questionnaire; 
[29]), two stages of pubertal development were assessed: gonadarche (breast and genital 
development) and adrenarche (pubic hair). Youth indicated their pubertal stage based on sex-
specific illustrations corresponding to Tanner stages I–V of prepubertal to complete sexual 
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maturity. This method has good reliability and validity against gold-standard physician 
examination (r = 0.77–0.91) [25, 27].
Sleep
Parents reported the child’s usual bed- and wake-times over the week (includes school and 
non-school nights). Typical sleep duration was calculated as the difference between bed- and 
wake-times. Subjective estimates of sleep duration show significant correlations with 
objective measures of sleep duration in youth (actigraphy: r = 0.53–0.79) [41, 49].
Gestational Age at Birth
Gestational age at birth (i.e., sum of pregnancy duration and chronological age of the child, 
calculated in weeks), birth weight (in grams), and pregnancy status (full-term vs. premature) 
were obtained from medical birth records.
Physical Activity, Medication, and Caffeine Intake
Parents reported whether their child exercised vigorously, consumed caffeine products (e.g., 
chocolate, energy drinks), or took medication 24 h prior to the ECG recording (response 
options yes or no).
Statistical Analyses
Data were entered, verified, and analyzed with IBM SPSS Statistics v.20 software (SPSS, 
Inc., Chicago, IL). Frequency-domain variables (VLF, LF, HF) were natural log transformed 
due to skewness. To yield normative values, mean and standard deviations were first derived 
for HRV parameters stratified by sex and heart rate reference ranges based on age at the 5th, 
25th, 50th, 85th, and 95th percentiles [44]. Next, linear regression analyses were used to 
determine the unique variance explained by each covariate for the HRV parameters. Finally, 
stepwise regression models were used to identify the most salient covariates, when all were 
entered simultaneously.
Results
Of the original 1,052 participants completing the cardiovascular screening at the QLSCD 
follow-up visit, 16 children were excluded due to missing ECG recordings (n = 12) or 
insufficient recording duration (<30 min, n = 4), yielding a final sample of 1,036. Participant 
demographics are presented in Table 1. Average gestational age at birth was 60.7 weeks (SD 
= 1.1), birth weight was 3,420.1 g (SD = 510.1), and 94.8 % were full-term. Children had no 
cardiovascular pathology (e.g., bradycardia, fibrillation, premature contraction) based on 
ECG review by a board-certified cardiologist (PP). ECG recordings were of excellent 
quality: >97 % of data were analyzable, artifact time was <8 min (0.09 %), and no 
recordings had >20 % noise or ectopic beats. Most children refrained from strenuous 
physical activity (96.4 %), caffeine (87.6 %), and medication use (82.0 %) for 24 h prior to 
the ECG recording.
Mean values and standard deviations for heart rate, RR intervals, and HRV variables are 
presented in Table 1. Sex differences were observed; boys had significantly greater HRV 
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values for all time-and frequency-domain variables. Due to age-related changes in heart rate 
[9, 44], normative HRV values are age- and sex-stratified and presented for the 5th, 25th, 
50th, 85th, and 95th heart rate percentiles (see Table 2).
Regression analyses revealed several significant covariates for HRV parameters. Overall, 
female sex, higher SBP, DBP, and heart rate, later recording start time, advanced pubertal 
development, and shorter sleep duration were associated with reduced HRV (Table 3). When 
all covariates were included in the models simultaneously, heart rate (βavg = −0.60, 
), ECG recording start time (βavg = −0.19, ), gonadarche puberty stage 
(βavg = −0.11, ), and DBP (βavg = 0.11, ) emerged as the most 
pronounced covariates across all the HRV parameters (data not shown for parsimony).
Discussion
Existing pediatric HRV normative values are limited, and developmental factors have not 
been systematically evaluated in children. The first objective was to provide time-and 
frequency-domain HRV values for a large, population-based sample of 10-year-old children. 
Compared to previously reported HRV values with short-term recordings (2–60 min) in 
same-aged children, the present study had comparable values for SDNN (M = 87 ms vs. 
range 60–72 ms) [19, 31, 45, 46], LF (in ms2: M = 1,493 ms2 vs. range 38.7–1,011 ms2 [19, 
31, 48]; log transformed: M = 7.1 vs. range 3.5–6.4 [4, 5, 26, 31]), HF (in ms2: M = 829 ms2 
vs. range 52–1,559 ms2 [19, 31, 48]; log transformed: M = 6.4 vs. range 3.9–6.3 [5, 26, 31]), 
and LF:HF ratio (M = 2.1 vs. range 0.8–4.51) [16, 31, 45, 48]. Compared to past studies, the 
present study obtained smaller values for rMSSD (M = 43 ms vs. range 55–72 ms) [19, 31, 
45, 48] and pNN50 (M = 19.7 % vs. range 26–64 %) [19, 48]. No comparisons could be 
made for SDANN and SDNNi, as they are infrequently reported in studies.
These discrepancies may be attributable to prior studies’ small sample sizes (e.g., N = 12; 
36), posture (e.g., seated vs. supine) [5], time of recording (e.g., upon awakening from sleep) 
[18], presentation of data reduction techniques (e.g., HRV values presented through graphs 
only) [8], inconsistencies in units (e.g., beats/min2, Hz) [7], and failure to adhere to the Task 
Force [39] recommendations for spectral analyses [7, 8]. Notedly, previously reported values 
fell within the 5th and 95th percentile values observed in the present population-based 
sample.
The second objective was to comprehensively assess the influence of developmental factors 
on HRV parameters. When covariates were assessed singularly, age, sex, pubertal stage, 
sleep duration, blood pressure, heart rate, and recording start time (i.e., time of day) all 
influenced HRV, which is consistent with previous adult findings [30, 36, 42]. However, 
when all covariates were considered together simultaneously, heart rate, gonadarche pubertal 
status, DBP, and ECG recording start times emerged as the most salient.
Age-related changes in HRV are likely attributable to age-related changes in heart rate [9, 
49]. Consistent with previous studies [4, 31, 37], sex differences emerged. Boys had lower 
heart rate and greater HRV, particularly HRV indices reflecting parasympathetic activity 
(SDNN, rMSSD, pNN50, HF) [6, 45]. Girls evidenced higher heart rate and greater 
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sympathovagal imbalance (LF:HF ratio) [31]. It was hypothesized that these sex differences 
were partly attributable to pubertal onset, as girls typically enter puberty 2 years earlier than 
boys [34]. Further, gestational age at birth, birth weight, and pregnancy status were not 
associated with any time- or frequency-domain variables.
Advanced pubertal development was associated with increased sympathovagal imbalance 
and reduced parasympathetic activity across time- and frequency-domain HRV variables 
(rMSSD, pNN50, HF; LF:HF ratio). These results are similar to previous research and 
support the notion that the timing of pubertal development coincides with the emergence and 
maturation of neural autonomic mechanisms [5, 6, 19, 29]. Similar to the limited pediatric 
data of other studies, shorter sleep duration was associated with reduced HRV [24, 32]. DBP 
was stronger than SBP at predicting VLF, SDNN, SDNNi, and rMSSD.
Also, later recording time (vs. earlier) was associated with reduced HRV parameters and 
sympathovagal imbalance, except rMSSD and pNN50. These findings may reflect circadian 
variations in the autonomic nervous system and HRV [50] and are consistent with past 
findings of decreasing HRV parameters over the day [12, 24].
Interestingly, when assessed separately, a significant association between 24-h physical 
activity and diminished sympathovagal imbalance in children was observed [5, 48]. 
However, while larger BMI was not associated with HRV, larger waist circumference was 
related to reduced VLF, which is partly consistent with past pediatric findings of greater 
obesity linked to reduced HRV [16, 22, 33].
Strengths, Limitations, and Future Recommendations
The first limitation included the use of 10-year-old children, limiting the generalizability of 
the results. However, unlike previous cross-sectional studies, with small sizes, wide age 
ranges, or clinical samples, this was the first study to present normative HRV values in a 
large, population-based sample of children. Given the prognostic significance of HRV for 
the progression of disease [1], repeated measures of HRV and covariates would be valuable 
to establish whether HRV is a stable intra-individual difference, which may increase its 
clinical utility (e.g., monitor risk stratification).
The second limitation was the use of, several covariates that were based on self- or parent-
report rather than objective assessment (e.g., accelerometer, pubertal development) [20, 45]. 
However, these self- or parent-report measures have demonstrated reliability and validity 
with objective measures [27]. Further, physiological covariates (e.g., blood pressure) were 
objectively assessed following standardized protocols.
Conclusion
Normative time- and frequency-domain HRV values for a large, population-based sample of 
10-year-old children are provided. Pediatric reference ranges of short-term HRV parameters 
permit comparison to assess values and may help promote use in clinical settings.
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